ArticleVirology journal2026
Predictive value and mechanism of LINC00665 for liver dysfunction in pregnant women with hepatitis B during early pregnancy.
Article in Virology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the expression characteristics of LINC00665 in early pregnancy and its predictive value for liver dysfunction in pregnant women with hepatitis B virus (HBV), along with elucidating the underlying molecular mechanisms.
methodsA total of 242 pregnant women with HBV and 110 healthy pregnant women were enrolled. Serum levels of LINC00665 were quantified using RT-qPCR, and its predictive efficacy was assessed via ROC curve and multivariate Logistic regression. An HBV-transfected L02 hepatocyte model was established to examine the effects of LINC00665 silencing. The LINC00665/miR-98-5p/CCND2 axis was identified through bioinformatics analysis, dual-luciferase reporter assays, and RIP assays.
resultsElevated serum LINC00665 levels were observed in pregnant women with hepatitis B, with further increases in those experiencing hepatic dysfunction. LINC00665 silencing enhanced cell viability, reduced apoptosis, and decreased levels of TNF-α, IL-6 and liver injury markers (ALT, AST). Mechanistically, LINC00665 functioned as a molecular sponge for miR-98-5p, thereby alleviating its inhibitory effect on CCND2.
conclusionSerum LINC00665 serves as a sensitive biomarker for predicting hepatic dysfunction in pregnant women with hepatitis B. The LINC00665/miR-98-5p/CCND2 axis plays a crucial role in HBV-transfected hepatocyte injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.